Phase II trial of whole-cell pertussis vaccine vs an acellular vaccine containing agglutinogens
- 12 January 1991
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 337 (8733), 70-73
- https://doi.org/10.1016/0140-6736(91)90735-8
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Secondary analyses of the efficacy of two acellular pertussis vaccines evaluated in a Swedish phase III trialVaccine, 1990
- Haemophilus influenzae infections and whooping coughThe Lancet, 1990
- Serotyping Bordetella pertussis strainsVaccine, 1989
- Serospecific protection of mice against intranasal infection with Bordetella pertussisVaccine, 1989
- PLACEBO-CONTROLLED TRIAL OF TWO ACELLULAR PERTUSSIS VACCINES IN SWEDEN—PROTECIVE EFFICACY AND ADVERSE EVENTSThe Lancet, 1988
- Trial of a new acellular pertussis vaccine in healthy adult volunteersVaccine, 1988
- SYMPTOMS AFTER PRIMARY IMMUNISATION WITH DTP AND WITH DT VACCINEThe Lancet, 1984
- Prevalent serotypes ofBordetella pertussisin non-vaccinated communitiesEpidemiology and Infection, 1976